RedHill Biopharma (RDHL) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $16.54 | |||
| Open | $0.46 | 52 Week Low | $8.10 | |||
| Day High | $0.47 | P/E | N/A | |||
| Day Low | $0.45 | EPS | $0.00 | |||
| Volume | 3,394 | |||||
